miR‐106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS
Citations Over TimeTop 10% of 2012 papers
Abstract
Emerging evidence has shown the association of aberrantly expressed miR-106a with cancer development, however, little is known about its potential role in gastric carcinogenesis. In our present study, obviously overexpressed miR-106a was found in gastric cancer tissues compared with their nontumor counterparts. Suppression of miR-106a significantly inhibited gastric cancer cell proliferation and triggered apoptosis. Bioinformatic analysis combining with validation experiments identified FAS as a direct target of miR-106a. Rescue experiments and examination of caspase-8, PARP and caspase-3 further approved that miR-106a could inhibit gastric cancer cell apoptosis through interfering with FAS-mediated apoptotic pathway. Moreover, a significant inverse correlation was found between miR-106a and FAS expression not only in gastric cancer cell lines but also in gastric cancer specimens. Taken together, these findings suggest that ectopicly overexpressed miR-106a may play an oncogenic role in gastric carcinogenesis and impair extrinsic apoptotic pathway through targeting FAS.
Related Papers
- → Enzyme-Instructed Assembly and Disassembly Processes for Targeting Downregulation in Cancer Cells(2017)146 cited
- → Upregulation of β3-adrenoceptors—a general marker of and protective mechanism against hypoxia?(2019)10 cited
- → Downregulation of POLD4 in Calu6 cells results in G1-S blockage through suppression of the Akt-Skp2-p27 pathway(2014)8 cited
- → Downregulation of p21/WAF1 Expression by Thymidylate Synthase(2001)17 cited
- → Viral Infection and Abnormal Brain Development: A DNA Microarray Study(2007)1 cited